2010 CONSULTATION RESPONSES

The Royal Pharmaceutical Society responded to the following consultations in 2010.

February 2010

MLX 366: Intention to amend the medicines for human use (prescribing by EEA practitioners) regulations 2008 (SI 2008/1692) | Medicines and Healthcare products Regulatory Agency

Pharmacy in England: building on strengths – delivering the future. Draft regulations under the Health Act 2009: Pharmaceutical Needs Assessments RPSGB response | Department of Health

March 2010

Arm 65 – Request to Reclassify Algopain - Eze 140mg medicated plaster from POM to P | Medicines and Healthcare products Regulatory Agency

Consultation on measures to strengthen the medicines supply chain and reduce the risk from counterfeit medicines | Medicines and Healthcare products Regulatory Agency

Consultation on the proposals to implement 'Generic Substitution' in primary care further to the Pharmaceutical Price Regulation Scheme (PPRS) | Department of Health

April 2010

Consultation on the revised performance review process and standards | Council for Healthcare Regulatory Excellence

Public consultation (MLX 364): The regulation of nicotine containing products (NCPs) | Medicines and Healthcare products Regulatory Agency

Arm 68 Ibuleve Speed Relief Max Strength Gel 10% w/w | Medicines and Healthcare products Regulatory Agency 

Arm 66 – Extended Maximum Treatment Period and Pack Size Changes to a Pharmacy Medicine | Medicines and Healthcare products Regulatory Agency

May 2010

Response from the RPSGB National Pharmacy Boards to the Consultation on the revised draft standards for the General Pharmaceutical Council | General Pharmaceutical Council

A response from the Royal Pharmaceutical Society of Great Britain to the consultation on the duty of co-operation regulations | Department of Health

Consultation on the revised draft standards for the General Pharmaceutical Council | General Pharmaceutical Council

June 2010

Review of access to the NHS by foreign nationals RPSGB response | Department of Health

Arm 67 – Request to reclassify Regaine for Men Extra Strength Scalp Solution 5% w/v Cutaneous Solution from P to GSL | Medicines and Healthcare products Regulatory Agency

Fitness to practise audit report (February 2010) | Council for Healthcare Regulatory Excellence

July 2010

NCAS contribution to revalidation | National Clinical Assessment Service

Public consultation on continuing need for a controlled activity category in the vetting and barring scheme | Department for Children, Schools and Families

Your choice of GP practice: a consultation on how to enable people to register with the GP practice of their choice | Department of Health

August 2010

Phase 2 proposals to amend the ABPI Code of Practice for the Pharmaceutical Industry | Prescription Medicines Code of Practice Authority

Proposals to amend the ABPI Code of Practice for the Pharmaceutical Industry 2008 | Prescription Medicines Code of Practice Authority

September 2010

Consultation on the Fitness to Practise Adjudication for health professionals: Assessing different mechanisms for delivery | Department of Health

Consultation MLX 370 – Intention to amend EEA Regulations 2008 | Medicines and Healthcare products Regulatory Agency

Public consultation on the Veterinary Medicines Regulations 2010 | Veterinary Medicines Directorate

November 2010

Informal consultation on the provisions for patient group directions and other matters | Medicines and Healthcare products Regulatory Agency

Review of medicines legislation: Informal consultation on the Medicines Act 1968 exemptions for sale, supply and administration of medicines. | Medicines and Healthcare products Regulatory Agency

Consultation on draft guidance on advertising homeopathic medicines | Medicines and Healthcare products Regulatory Agency

December 2010

Medicines legislation consolidation and review project | Medicines and Healthcare products Regulatory Agency

ARM 69 Nicorette 15mg Inhalator | Medicines and Healthcare products Regulatory Agency

Arm 71 Radian B Ibuprofen 5%w/w gel 100g | Medicines and Healthcare products Regulatory Agency

Expanding the list of "never events": Policy proposals for engagement | Department of Health

Return To Top